Extracellular vesicles and cardiovascular disease therapy

Area of Science:

• Regenerative Medicine
• Cardiovascular Research
• Biotechnology

Background:

• Cardiovascular disease (CVD) is a leading global cause of death.
• Acute myocardial infarction (AMI) survivors face risks of heart failure due to cardiac remodeling.
• Current stem cell therapies face safety and ethical challenges.

Purpose of the Study:

• To review the functional relevance of stem cell-derived extracellular vesicles (EVs) in cardiovascular regenerative medicine.
• To detail the molecular pathways targeted by these EVs.
• To discuss the advantages and limitations of EV-based therapy for clinical translation.

Main Methods:

• Literature review of studies on stem cell-derived EVs in cardiovascular applications.
• Analysis of molecular mechanisms underlying EV therapeutic effects.
• Comparative assessment of EV therapy versus cell therapy.

Main Results:

• Stem cell-derived EVs effectively mimic the regenerative properties of parental stem cells.
• EVs utilize specific molecular pathways to promote cardiac repair.
• Acellular EV therapy presents advantages over cell-based approaches.

Conclusions:

• Stem cell-derived EVs represent a viable acellular therapeutic alternative for cardiovascular regenerative medicine.
• Further research is needed to overcome limitations for clinical translation.
• EVs offer a promising avenue to address heart failure post-AMI.